The Global Organisation for EPA and DHA Omega-3s (GOED) has announced the publication of a review the organisation commissioned on the state of omega-3 diagnostics testing.
‘Omega-3 Polyunsaturated Fatty Acid Status Testing in Humans: A Narrative Review of Commercially Available Options,’ published in The Journal of Nutrition, highlights the landscape of available omega-3 tests and the importance of diagnostics testing for improving EPA and DHA consumption.
This review provides an overview of the options available for measuring omega-3 long-chain polyunsaturated fatty acids (LCPUFA) status, including both dietary assessments and commercially available analytical tests of blood and breast milk samples.
The publication also showcases the evidence linking increased omega-3 LCPUFA intake or status to improved health, focusing on cardiovascular, neurological, pregnancy and eye health outcomes.
Harry B. Rice, GOED’s Vice-President of Regulatory & Scientific Affairs noted: “Seeing the overview of scientific evidence on omega-3 levels and health outcomes really gives you a sense of where the strongest evidence exists and where there might be gaps.”
GOED commissioned this paper as part of its work to support diagnostics as a key tool for increasing omega-3 consumption globally.
